UK supply of new meningitis vaccines goes to tender
This article was originally published in Scrip
Which of the two new meningitis vaccines, GlaxoSmithKline's Synflorix or Wyeth's Prevenar 13, will be used in the UK NHS is to be decided by tender, according to health minister Gillian Merron.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
France’s fledgling biotech Dynacure has pulled together a series C funding round to support its ongoing Phase I/II study of an antisense molecule for an ultrarare myopathy.